News

Filter

Current filters:

IpsenMetabolics

Ipsen drops BIM 23A760 development on disappointing Ph IIb results

16-12-2010

French drugmaker Ipsen (Euronext: IPN) says that the preliminary data from the ongoing Phase IIb study…

IpsenMetabolicsPharmaceuticalResearchSomatuline

COMPANY SPOTLIGHT

Menarini

Back to top